Storage and Shipment. 8.1 External Manufacturer specifically waives any and all liens and/or security interests in any of the Product and any Materials which it might acquire by operation of law, by judicial process, by judgment or otherwise.
Storage and Shipment. Fresenius will store the PRODUCTS under cGMP conditions with appropriate temperature control, and ensure that appropriate controls are in place to prevent interference, theft, product contamination and mixture with any other products or materials. Fresenius will be responsible for affixing all labels, container sealing and integrity, storage and shipping conditions for the PRODUCTS. Fresenius will maintain proper segregation of the PRODUCTS. TransMedics shall be permitted to review Fresenius’s segregation system. Different lots of single PRODUCT or different types of products will not be mixed on a pallet. Fresenius will suitably pack the PRODUCTS in appropriate shippers for transit. Fresenius will ensure that during packaging, storage and shipment of the PRODUCT there is no possibility of deterioration, contamination or admixture with any other materials. Protocols for testing of packaging components shall be mutually agreed upon by the Parties. Fresenius will only deliver PRODUCTS FCA to TransMedics carrier, or as otherwise agreed to by the parties in writing. THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Only approved, finished PRODUCTS will be shipped by Fresenius to TransMedics, except as otherwise provided. Fresenius will not ship any PRODUCT that is unapproved or under quarantine, unless mutually agreed by the parties.
Storage and Shipment. 5.6.1 CATALENT will store the bulk PRODUCT under conditions specified by PRODUCT label requirements as supplied by INTERMUNE. CATALENT will ensure that during storage before shipping of the PRODUCT, appropriate controls are in place to insure that there is no interference, theft, contamination, or mixture with any other products or materials. INTERMUNE will provide details of any labeling requirements, container sealing and integrity, and storage and shipping conditions for the PRODUCT.
Storage and Shipment. 5.10.1 Storage - C*P will store the PRODUCTS (Schedule IV controlled substances) under conditions in compliance with applicable DEA regulations and approved by CLIENT. C*P will ensure that during storage before shipping of the PRODUCTS that there is no possibility of deterioration, interference, theft, product contamination, or admixture with any other materials. CLIENT will provide details of any labeling requirements and container sealing and integrity.
Storage and Shipment. 5.10.1 Storage - C*P will store the PRODUCTS under conditions approved by ORPHAN as listed in the specifications. C*P will ensure that during storage before shipping of the PRODUCTS that appropriate controls are in place to ensure no interference, theft, product contamination, or admixture with any other materials. ORPHAN will provide details of any labeling requirements and container sealing and integrity.
Storage and Shipment. 7.1 Co-Packer agrees to load and ship the Product, F.O.B. Dock, Co-Packer’s plant in Osceola, Arkansas, on such carriers, to such destinations, and in such quantities as may be designated by the Company. The xxxx of lading should include Product description, Product number, and release order number.
Storage and Shipment. (a) Storage. Nastech will store the Product under conditions specified by product label requirements. Nastech will ensure that during storage before shipping of the Product appropriate controls are in place to ensure that there is no interference, theft, product contamination, or mixture with any other products or materials. LICENSEE will provide details of any labeling requirements, container sealing and integrity, and storage and shipping conditions for the Product.
Storage and Shipment. 5.10.1 Storage - C*P will store the PRODUCTS under conditions approved by POZEN. C*P will ensure that during storage before shipping of the PRODUCTS that appropriate controls are in place to ensure no interference, theft, product contamination, or admixture with any other materials. POZEN will provide details of any labeling requirements and container sealing and integrity.
Storage and Shipment. (a) SPAFAS will be responsible for storing all BDA at its facilities, packaging the BDA in a manner acceptable to EMBREX, segregating EMBREX owned BDA from SPAFAS owned BDA, protecting and insuring the BDA until it is shipped, and preparing BDA for shipment in a manner which will minimize risks of damage to the BDA and in accordance with the Terms of this Agreement.
Storage and Shipment. When the PRODUCTS are in the possession, custody or control of a Party, such Party will (i) store the PRODUCTS under cGMP conditions with appropriate temperature control, and (ii) ensure that appropriate controls are in place to prevent interference, theft, product contamination and mixture with any other products or materials. SkyePharma will suitably pack the unlabeled PRODUCTS in validated shippers for transit. At least one(l) temperature monitor will be included in each shipping container. Shipments will be arranged for next day delivery. Shipments will not be made on Thursday or Friday unless prior written approval from Enzon is received. Only interim approved, unlabeled PRODUCTS will be shipped by SkyePharma to Enzon in accordance with Appendix III attached hereto, except as otherwise provided. SkyePharma will not skip any PRODUCT that is unapproved or under quarantine, unless mutually agreed by the parties. When the PRODUCTS are in the possession, custody or control of a Party, such Party will maintain proper segregation of the PRODUCTS. Each Party shall be permitted to review the other Party’s segregation systems. Different lots of a single PRODUCT or different types of products will not be mixed on a pallet.
